Natriuretic response to increased pressure is preserved with COX-2 inhibitors

Hypertension

Volumn 34, Issue 5, 1999, Pages 1163-1167

  Gross, Jennifer M ^a   Dwyer, Jennifer E ^a   Knox, Franklyn G ^a  

^a MAYO CLINIC   (United States)

Author keywords

Kidney; Prostaglandins; Sodium

Indexed keywords

MELOXICAM; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PIROXICAM; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; ENZYME INHIBITION; HYDROSTATIC PRESSURE; KIDNEY INTERSTITIUM; MALE; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM EXCRETION;

EID: 0032732795     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.34.5.1163     Document Type: Article

References (30)

1. Khraibi AA, Haas JA, Knox FG. Effect of renal perfusion pressure on renal interstitial hydrostatic pressure in rats. Am J Physiol. 1989;256: F165-F170.
2. Garcia-Estan J, Roman RJ. Role of renal interstitial hydrostatic pressure in the pressure diuresis response. Am J Physiol. 1989;256:F63-F70.
3. Khraibi AA, Knox FG. Effect of renal decapsulation on renal interstitial hydrostatic pressure and natriuresis. Am J Physiol. 1989;257:R44-R48.
4. Khraibi AA, Knox FG. Effect of acute renal decapsulation on pressure natriuresis in SHR and WKY rats. Am J Physiol. 1989;257:F785-F789.
5. Granger JP, Haas JA, Pawlowska D, Knox FG. Effect of direct increases in renal interstitial hydrostatic pressure on sodium excretion. Am J Physiol. 1988;254:F527-F532.
6. Carmines PK, Bell PD, Roman RJ, Work J, Navar LG. Prostaglandins in the sodium excretory response to altered renal arterial pressure in dogs. Am J Physiol. 1985;248:F8-F14.
7. Pawlowska D, Haas JA, Granger JP, Romero JC, Knox FG. Prostaglandin blockade blunts the natriuresis of elevated renal interstitial hydrostatic pressure. Am J Physiol. 1988;254:F507-F511.
8. Haas JA, Knox FG. Effect of meclofenamate or ketoconazole on the natriuretic response to increased pressure. J Lab Clin Med. 1996;128: 202-207.
9. Kujubu DA, Fletcher BS, Varnum CR, Lim W, Herschman H. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem. 1991;266:12866-12872.
10. Xie W, Chipman JG, Robertson DL, Erikson RL, Simmons DL. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci U S A. 1991;88:2692-2696.
11. Smith WL, Garavito MR, De Witt DL. Prostaglandin endoperoxide H synthase (cyclooxygenase)-1 and -2. J Biol Chem. 1996;271: 33157-33160.
12. Yang T, Singh I, Pham H, Sun D, Smart A, Schnermann JB, Briggs JP. Regulation of cyclooxygenase expression in the kidney by dietary salt intake. Am J Physiol. 1998;274:F481-F489.
13. Harris RC, McKanna JA, Akai Y, Jacobson HR, Dubois RN, Breyer MD. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J Clin Invest. 1994;94:2504-2510.
14. Jensen BL, Kurtz A. Differential regulation of renal cyclooxygenase mRNA by dietary salt intake. Kidney Int. 1997;52:1242-1249.
15. Masferrer JL, Zweifel BS, Manning PT, Hauser SD, Leahy KM, Smith WG, Isakson PC, Scibert K. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc Natl Acad Sci U S A. 1994;91:3228-3232.
16. Engelhardt G, Homma D, Schlegel K, Utzmann R, Schnitzler C. Antiinflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favorable gastrointestinal tolerance. Inflamm Res. 1995;44:423-433.
17. Futaki N, Takanashi S, Yokoyama M, Arai I, Higuchi S, Otomo S. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins. 1994;47:55-59.
18. Engelhardt G, Boegel R, Schnitzer C, Utzmann R. Meloxicam: influence on arachidonic acid metabolism, I: in vitro findings. Biochem Pharmacol. 1995;51:21-28.
19. Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci U S A. 1993; 90:11693-11697.
20. Foehr J, Kaczmarczyk J, Kroettgen CD. Eine einfache colorimetrische Methode zur Inulinbestimmung fuer Nieren-Clearance-Untersuchungen bei Stoffwechselgesunden and Diabetikern. Klin Wochenschr. 1955;33: 729-730.
21. Haas J, Granger JP, Knox FG. Effect of meclofenamate on lithium excretion in response to changes in renal perfusion pressure. J Lab Clin Med. 1988;111:543-547.
22. Kinoshita Y, Knox FG. Response of superficial proximal convoluted tubule to decreased and increased renal perfusion pressure: in vivo microperfusion study in rats. Circ Res. 1989;66:1184-1189.
23. Haas JA, Granger JP, Knox FG. Effect of renal perfusion pressure on sodium reabsorption from proximal tubules of superficial and deep nephrons. Am J Physiol. 1986;250:F425-F429.
24. Kinoshita Y, Knox FG. Role of prostaglandins in proximal tubule sodium reabsorption: response to elevated renal interstitial hydrostatic pressure. Circ Res. 1989;64:1013-1018.
25. Stichtenoth DO, Wagner B, Froelich JC. Effect of meloxicam and indomethacin on cyclooxygenase pathways in healthy volunteers. J Invest Med. 1997;45:44-49.
26. 2 in pressure natriuresis. Am J Physiol. 1991;260:F643-F649.
27. Palmer BF. Renal complications associated with use of nonsteroidal anti-inflammatory agents. J Invest Med. 1995;43:516-533.
28. Gurwitz JH, Avorn J, Bohn RL, Glynn RJ, Monane M, Mogun H. Initiation of antihypertensive treatment during nonsteroidal antiinflammatory drug therapy. JAMA. 1994;272:781-786.
29. Vane JR, Botting JH, Botting RM. Improved Nonsteroid Antiinflammatory Drugs: COX-2 Enzyme Inhibitors. Dordrecht, Netherlands: Kluwer Academic Publishers, William Harvey Press; 1996.
30. Harding P, Sigmon DH, Alfie ME, Huang PL, Fishman MC, Beierwaltes WH, Carretero OA. Cyclooxygenase-2 mediates increased renal renin content induced by low-sodium diet. Hypertension. 1997;29:297-302.